25th American Pharma and Biotech Project, Program and Portfolio Management Conference 2025 | Why Summits | 11 June 2025 | TBA, San Francisco, CA, USA

This conference in San Francisco dives right into the cutting edge of project and portfolio management.

The event, which is part of our PPM World Tour, gathers 30+ industry leaders sharing their expertise, providing an exceptional space for networking and knowledge-sharing. From harnessing the power of artificial intelligence in PPM to mastering the balance between portfolio management and corporate strategy, the conference unpacks the latest innovations shaping the pharma industry.

Dive into sessions that reveal the future of managing cross-functional teams, hybrid project management models, and game changing decision-making techniques. With a focus on bold solutions to modern challenges, the conference promises transformative insights that will redefine the way pharma drives progress and innovation. Join us in the sunny San Francisco to connect with the best in the business and be part of the future of pharma PPM!

Main takeaways:
• Optimizing the utilization of AI tools in PPM
• Leading the future: Strategy, Innovation & Transformation
• Mastering cross-functional team strategies & collaboration
• The “Winning Formula”: Identifying & implementing the right tools and methods
• Small & Big Pharma: Growth, leadership & best practices
• Innovative approaches to contemporary challenges in pharma & biotech PPM
• Workshop: The psychic tole of the PM/PMO in preparing for due diligence
• Workshop: The “1-3-1” hack for decision-making

2025 Speakers

Tilo Senger
Head of Global R&D Project Leadership, EMD Serono

Sara Bender
SVP, Corporate Strategy & Transformation, Chief of Staff, iRhythm Technologies Inc.

Neeta Mhatre
Vice President, China Strategy & Operations, Intuitive

Michael Faia
Head of R&D Portfolio Management, Harmony Biosciences

Marie Spark
PM Educational Consultant, PMI San Francisco

Maithili Dalvi
Associate Director, Global Commercial Project Management, Gilead Sciences

Courtland LaVallee
Biopharmaceutical Program Management, Expert

Amy Ambrosini
Senior Director, Strategy and Business Operations, BMS

Alaina Kupec
Executive Director,Portfolio Strategy & Analytics, Gilead Sciences

Chris Vandepas
Director Portfolio Program Management, Guardant Health

Chris Knight
Director, Program Management, Formation Bio

Dave Penndorf
PPM Advisor, Groundswell Pharma Consulting

Andrea Espitia
Director of Project Management, Synthego Corporation

Stephen Smith
Senior Program Director, Oncology, Corcept Therapeutics

Monika Sharma
Vice President, Product Development & Leadership, Diagonal Therapeutics

Lulu Yang
People, Growth & Transformation Leader, Genentech

Joe Stalder
VP Program Management, Zentalis Pharmaceuticals

Elise Brownell
Founder, Zephyr Biotech

2025 Partner

GOLD PARTNER:
• Integrated Project Management Company